Logo image of EWL.DE

EDWARDS LIFESCIENCES CORP (EWL.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:EWL - US28176E1082 - Common Stock

73.57 EUR
-0.02 (-0.03%)
Last: 11/24/2025, 7:00:00 PM
Fundamental Rating

7

Overall EWL gets a fundamental rating of 7 out of 10. We evaluated EWL against 63 industry peers in the Health Care Equipment & Supplies industry. EWL has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. EWL is quite expensive at the moment. It does show a decent growth rate. This makes EWL very considerable for quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year EWL was profitable.
EWL had a positive operating cash flow in the past year.
In the past 5 years EWL has always been profitable.
In the past 5 years EWL always reported a positive cash flow from operatings.
EWL.DE Yearly Net Income VS EBIT VS OCF VS FCFEWL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1.2 Ratios

With an excellent Return On Assets value of 10.31%, EWL belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
EWL has a better Return On Equity (13.40%) than 77.78% of its industry peers.
EWL's Return On Invested Capital of 9.83% is amongst the best of the industry. EWL outperforms 80.95% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EWL is above the industry average of 9.33%.
Industry RankSector Rank
ROA 10.31%
ROE 13.4%
ROIC 9.83%
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
EWL.DE Yearly ROA, ROE, ROICEWL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

EWL's Profit Margin of 23.25% is amongst the best of the industry. EWL outperforms 93.65% of its industry peers.
In the last couple of years the Profit Margin of EWL has grown nicely.
The Operating Margin of EWL (27.73%) is better than 96.83% of its industry peers.
EWL's Operating Margin has been stable in the last couple of years.
EWL has a better Gross Margin (78.19%) than 92.06% of its industry peers.
EWL's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 27.73%
PM (TTM) 23.25%
GM 78.19%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
EWL.DE Yearly Profit, Operating, Gross MarginsEWL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

10

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), EWL is creating some value.
EWL has less shares outstanding than it did 1 year ago.
The number of shares outstanding for EWL has been reduced compared to 5 years ago.
Compared to 1 year ago, EWL has an improved debt to assets ratio.
EWL.DE Yearly Shares OutstandingEWL.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
EWL.DE Yearly Total Debt VS Total AssetsEWL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

EWL has an Altman-Z score of 12.53. This indicates that EWL is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 12.53, EWL belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
EWL has a debt to FCF ratio of 0.75. This is a very positive value and a sign of high solvency as it would only need 0.75 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.75, EWL belongs to the top of the industry, outperforming 93.65% of the companies in the same industry.
A Debt/Equity ratio of 0.06 indicates that EWL is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.06, EWL belongs to the best of the industry, outperforming 87.30% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.75
Altman-Z 12.53
ROIC/WACC1.14
WACC8.59%
EWL.DE Yearly LT Debt VS Equity VS FCFEWL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 4.00 indicates that EWL has no problem at all paying its short term obligations.
With an excellent Current ratio value of 4.00, EWL belongs to the best of the industry, outperforming 90.48% of the companies in the same industry.
A Quick Ratio of 3.29 indicates that EWL has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 3.29, EWL belongs to the top of the industry, outperforming 90.48% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4
Quick Ratio 3.29
EWL.DE Yearly Current Assets VS Current LiabilitesEWL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

The earnings per share for EWL have decreased by -3.75% in the last year.
EWL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.13% yearly.
EWL shows a small growth in Revenue. In the last year, the Revenue has grown by 4.67%.
Measured over the past years, EWL shows a small growth in Revenue. The Revenue has been growing by 4.58% on average per year.
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%

3.2 Future

EWL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.50% yearly.
Based on estimates for the next years, EWL will show a quite strong growth in Revenue. The Revenue will grow by 8.55% on average per year.
EPS Next Y0.42%
EPS Next 2Y5.67%
EPS Next 3Y7.57%
EPS Next 5Y9.5%
Revenue Next Year4.33%
Revenue Next 2Y7.03%
Revenue Next 3Y7.98%
Revenue Next 5Y8.55%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EWL.DE Yearly Revenue VS EstimatesEWL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
EWL.DE Yearly EPS VS EstimatesEWL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 33.14 indicates a quite expensive valuation of EWL.
The rest of the industry has a similar Price/Earnings ratio as EWL.
EWL's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 25.98.
The Price/Forward Earnings ratio is 29.05, which means the current valuation is very expensive for EWL.
The rest of the industry has a similar Price/Forward Earnings ratio as EWL.
EWL's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 35.79.
Industry RankSector Rank
PE 33.14
Fwd PE 29.05
EWL.DE Price Earnings VS Forward Price EarningsEWL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

EWL's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EWL is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 62.4
EV/EBITDA 25.44
EWL.DE Per share dataEWL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
EWL has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)78.19
PEG (5Y)4.65
EPS Next 2Y5.67%
EPS Next 3Y7.57%

0

5. Dividend

5.1 Amount

No dividends for EWL!.
Industry RankSector Rank
Dividend Yield N/A

EDWARDS LIFESCIENCES CORP

FRA:EWL (11/24/2025, 7:00:00 PM)

73.57

-0.02 (-0.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-30 2025-10-30/amc
Earnings (Next)02-09 2026-02-09/amc
Inst Owners88.08%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap43.19B
Revenue(TTM)5.88B
Net Income(TTM)1.37B
Analysts77.67
Price Target81.31 (10.52%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.01%
Min EPS beat(2)4.4%
Max EPS beat(2)9.63%
EPS beat(4)4
Avg EPS beat(4)5.38%
Min EPS beat(4)3.4%
Max EPS beat(4)9.63%
EPS beat(8)5
Avg EPS beat(8)2.27%
EPS beat(12)6
Avg EPS beat(12)1.21%
EPS beat(16)7
Avg EPS beat(16)-0.18%
Revenue beat(2)1
Avg Revenue beat(2)0.37%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)0.85%
Revenue beat(4)1
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-2.1%
Max Revenue beat(4)0.85%
Revenue beat(8)1
Avg Revenue beat(8)-2.7%
Revenue beat(12)2
Avg Revenue beat(12)-2.12%
Revenue beat(16)2
Avg Revenue beat(16)-2.48%
PT rev (1m)6.1%
PT rev (3m)6.62%
EPS NQ rev (1m)0.9%
EPS NQ rev (3m)1.59%
EPS NY rev (1m)2.02%
EPS NY rev (3m)2.35%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)-0.06%
Revenue NY rev (1m)0.62%
Revenue NY rev (3m)0.63%
Valuation
Industry RankSector Rank
PE 33.14
Fwd PE 29.05
P/S 8.48
P/FCF 62.4
P/OCF 49.07
P/B 4.89
P/tB 6.83
EV/EBITDA 25.44
EPS(TTM)2.22
EY3.02%
EPS(NY)2.53
Fwd EY3.44%
FCF(TTM)1.18
FCFY1.6%
OCF(TTM)1.5
OCFY2.04%
SpS8.68
BVpS15.05
TBVpS10.77
PEG (NY)78.19
PEG (5Y)4.65
Graham Number27.42
Profitability
Industry RankSector Rank
ROA 10.31%
ROE 13.4%
ROCE 13.97%
ROIC 9.83%
ROICexc 14.65%
ROICexgc 23.24%
OM 27.73%
PM (TTM) 23.25%
GM 78.19%
FCFM 13.59%
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
ROICexc(3y)16.13%
ROICexc(5y)17.4%
ROICexgc(3y)22.87%
ROICexgc(5y)24.4%
ROCE(3y)17.66%
ROCE(5y)19.29%
ROICexgc growth 3Y-5.47%
ROICexgc growth 5Y-8.01%
ROICexc growth 3Y-11.82%
ROICexc growth 5Y-8.6%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.75
Debt/EBITDA 0.33
Cap/Depr 138.79%
Cap/Sales 3.69%
Interest Coverage 250
Cash Conversion 56.86%
Profit Quality 58.45%
Current Ratio 4
Quick Ratio 3.29
Altman-Z 12.53
F-Score6
WACC8.59%
ROIC/WACC1.14
Cap/Depr(3y)185.14%
Cap/Depr(5y)236.01%
Cap/Sales(3y)5.48%
Cap/Sales(5y)6.41%
Profit Quality(3y)37.92%
Profit Quality(5y)57.13%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.75%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%0%
EPS Next Y0.42%
EPS Next 2Y5.67%
EPS Next 3Y7.57%
EPS Next 5Y9.5%
Revenue 1Y (TTM)4.67%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%14.67%
Revenue Next Year4.33%
Revenue Next 2Y7.03%
Revenue Next 3Y7.98%
Revenue Next 5Y8.55%
EBIT growth 1Y4.68%
EBIT growth 3Y-4.72%
EBIT growth 5Y3.49%
EBIT Next Year10.47%
EBIT Next 3Y11.73%
EBIT Next 5Y12.76%
FCF growth 1Y1.45%
FCF growth 3Y-42.99%
FCF growth 5Y-22.01%
OCF growth 1Y-2.42%
OCF growth 3Y-32.1%
OCF growth 5Y-14.39%

EDWARDS LIFESCIENCES CORP / EWL.DE FAQ

Can you provide the ChartMill fundamental rating for EDWARDS LIFESCIENCES CORP?

ChartMill assigns a fundamental rating of 7 / 10 to EWL.DE.


Can you provide the valuation status for EDWARDS LIFESCIENCES CORP?

ChartMill assigns a valuation rating of 2 / 10 to EDWARDS LIFESCIENCES CORP (EWL.DE). This can be considered as Overvalued.


What is the profitability of EWL stock?

EDWARDS LIFESCIENCES CORP (EWL.DE) has a profitability rating of 8 / 10.


What is the valuation of EDWARDS LIFESCIENCES CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for EDWARDS LIFESCIENCES CORP (EWL.DE) is 33.14 and the Price/Book (PB) ratio is 4.89.


How financially healthy is EDWARDS LIFESCIENCES CORP?

The financial health rating of EDWARDS LIFESCIENCES CORP (EWL.DE) is 10 / 10.